BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37476329)

  • 1. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
    Galbraith K; Vasudevaraja V; Serrano J; Shen G; Tran I; Abdallat N; Wen M; Patel S; Movahed-Ezazi M; Faustin A; Spino-Keeton M; Roberts LG; Maloku E; Drexler SA; Liechty BL; Pisapia D; Krasnozhen-Ratush O; Rosenblum M; Shroff S; Boué DR; Davidson C; Mao Q; Suchi M; North P; Hopp A; Segura A; Jarzembowski JA; Parsons L; Johnson MD; Mobley B; Samore W; McGuone D; Gopal PP; Canoll PD; Horbinski C; Fullmer JM; Farooqui MS; Gokden M; Wadhwani NR; Richardson TE; Umphlett M; Tsankova NM; DeWitt JC; Sen C; Placantonakis DG; Pacione D; Wisoff JH; Teresa Hidalgo E; Harter D; William CM; Cordova C; Kurz SC; Barbaro M; Orringer DA; Karajannis MA; Sulman EP; Gardner SL; Zagzag D; Tsirigos A; Allen JC; Golfinos JG; Snuderl M
    Neurooncol Adv; 2023; 5(1):vdad076. PubMed ID: 37476329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
    Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
    Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
    Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
    J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors.
    Rajappa P; Eng KW; Bareja R; Bander ED; Yuan M; Dua A; Bhanu Maachani U; Snuderl M; Pan H; Zhang T; Tosi U; Ivasyk I; Souweidane MM; Elemento O; Sboner A; Greenfield JP; Pisapia DJ
    Neurooncol Adv; 2022; 4(1):vdac031. PubMed ID: 35475276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors.
    Galbraith K; Serrano J; Shen G; Tran I; Slocum CC; Ketchum C; Abdullaev Z; Turakulov R; Bale T; Ladanyi M; Sukhadia P; Zaidinski M; Mullaney K; DiNapoli S; Liechty BL; Barbaro M; Allen JC; Gardner SL; Wisoff J; Harter D; Hidalgo ET; Golfinos JG; Orringer DA; Aldape K; Benhamida J; Wrzeszczynski KO; Jour G; Snuderl M
    Mol Cancer Res; 2024 Jan; 22(1):21-28. PubMed ID: 37870438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study.
    Schepke E; Löfgren M; Pietsch T; Olsson Bontell T; Kling T; Wenger A; Ferreyra Vega S; Danielsson A; Dosa S; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sandström PE; Pfister SM; Lannering B; Sabel M; Carén H
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12838. PubMed ID: 35892159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.
    Otani Y; Satomi K; Suruga Y; Ishida J; Fujii K; Ichimura K; Date I
    Brain Tumor Pathol; 2023 Apr; 40(2):56-65. PubMed ID: 37004583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Methylation Profiling in Rare Sellar Tumors.
    Wright K; Galbraith K; Snuderl M; Agrawal N
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study.
    Pickles JC; Fairchild AR; Stone TJ; Brownlee L; Merve A; Yasin SA; Avery A; Ahmed SW; Ogunbiyi O; Gonzalez Zapata J; Peary AF; Edwards M; Wilkhu L; Dryden C; Ladon D; Kristiansen M; Rowe C; Kurian KM; Nicoll JAR; Mitchell C; Bloom T; Hilton DA; Al-Sarraj S; Doey L; Johns PN; Bridges LR; Chakrabarty A; Ismail A; Rathi N; Syed K; Lammie GA; Limback-Stanic C; Smith C; Torgersen A; Rae F; Hill RM; Clifford SC; Grabovska Y; Williamson D; Clarke M; Jones C; Capper D; Sill M; von Deimling A; Pfister SM; Jones DTW; Hargrave D; Chalker J; Jacques TS
    Lancet Child Adolesc Health; 2020 Feb; 4(2):121-130. PubMed ID: 31786093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of DNA methylation profiling in neuro-oncology as a diagnostic support tool: A review.
    Singh J; Sahu S; Mohan T; Mahajan S; Sharma MC; Sarkar C; Suri V
    Neurooncol Pract; 2023 Dec; 10(6):518-526. PubMed ID: 38009119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong.
    Tam OCH; Ho RSL; Chan S; Li KKW; Lam TL; Cheung ETY; Cheung OY; Ho WWS; Cheng KKF; Shing MMK; Ku DTL; Chung BHY; Yang W; Chan GCF; Ng HK; Liu APY
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Implementation of DNA Methylation Profiling into a Multistep Diagnostic Process in Pediatric Neuropathology: A 2-Year Real-World Experience by the French Neuropathology Network.
    Pages M; Uro-Coste E; Colin C; Meyronet D; Gauchotte G; Maurage CA; Rousseau A; Godfraind C; Mokhtari K; Silva K; Figarella-Branger D; Varlet P; On Behalf Of The Renoclip-Loc Network
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature.
    Lopez-Nunez O; Cafferata B; Santi M; Ranganathan S; Pearce TM; Kulich SM; Bailey KM; Broniscer A; Rossi S; Zin A; Nasrallah MP; Li MM; Zhong Y; Miele E; Alaggio R; Surrey LF
    Brain Pathol; 2021 Jan; 31(1):70-83. PubMed ID: 32997853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience.
    Roohani S; Ehret F; Perez E; Capper D; Jarosch A; Flörcken A; Märdian S; Zips D; Kaul D
    Clin Epigenetics; 2022 Nov; 14(1):149. PubMed ID: 36380356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classification.
    Kling T; Ferreyra Vega S; Suman M; Dénes A; Lipatnikova A; Lagerström S; Olsson Bontell T; Jakola AS; Carén H
    Brain Pathol; 2024 Jan; ():e13233. PubMed ID: 38168467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.
    Azizgolshani N; Petersen CL; Chen Y; Levy JJ; Salas LA; Perreard L; Nguyen LN; Christensen BC
    Clin Epigenetics; 2021 Sep; 13(1):176. PubMed ID: 34538273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults.
    Ji J; Kaneva K; Hiemenz MC; Dhall G; Davidson TB; Erdreich-Epstein A; Hawes D; Hurth K; Margol AS; Mathew AJ; Robison NJ; Schmidt RJ; Tran HN; Judkins AR; Cotter JA; Biegel JA
    Neurooncol Adv; 2021; 3(1):vdab037. PubMed ID: 33948563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.
    White CL; Kinross KM; Moore MK; Rasouli E; Strong R; Jones JM; Cain JE; Sturm D; Sahm F; Jones DTW; Pfister SM; Robertson T; D'Arcy C; Rodriguez ML; Dyke JM; Junckerstorff R; Bhuva DD; Davis MJ; Wood P; Hassall T; Ziegler DS; Kellie S; McCowage G; Alvaro F; Kirby M; Heath JA; Tsui K; Dodgshun A; Eisenstat DD; Khuong-Quang DA; Wall M; Algar EM; Gottardo NG; Hansford JR
    J Mol Diagn; 2023 Oct; 25(10):709-728. PubMed ID: 37517472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors.
    Bertero L; Mangherini L; Ricci AA; Cassoni P; Sahm F
    Virchows Arch; 2024 Feb; 484(2):181-194. PubMed ID: 37658995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.